Interestingly, SOX9 has been reported to regulate β‐catenin expression positively in the canonical Wnt pathway and to influence the downstream effectors such as Cyclin D1 and c‐Myc to promote cancer progression (Santos et al., 2016). Here, CCND1 is linked to cancer.